WAY-100,635
Systematic (IUPAC) name | |
---|---|
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N-(2-pyridyl)cyclohexanecarboxamide
|
|
Identifiers | |
CAS Number | 146714-97-8 |
PubChem | CID: 5684 |
IUPHAR/BPS | 80 |
ChemSpider | 5482 |
ChEMBL | CHEMBL31354 |
Chemical data | |
Formula | C25H34N4O2 |
Molecular mass | 422.56 g/mol |
|
|
|
|
(what is this?) (verify) |
WAY-100,635 is a piperazine drug and research chemical widely used in scientific studies. It was originally believed to act as a selective 5-HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor.[1][2][3] It is sometimes referred to as a silent antagonist at the former receptor.[4] It is closely related to WAY-100,135.
In light of its only recently discovered dopaminergic activity, conclusions drawn from studies that employed WAY-100635 as a selective 5-HT1A antagonist may need to be re-evaluated.
Contents
Human PET studies
In human PET studies WAY-100,635 shows high binding in the cerebral cortex, hippocampus, raphe nucleus and amygdaloid nucleus, while lower in thalamus and basal ganglia.[5] One study described a single case with relatively high binding in the cerebellum.[6]
In relating its binding to subject variables one Swedish study found WAY-100,635 binding in raphe brain region correlating with self-transcendence and spiritual acceptance personality traits.[7] WAY-100,635 binding has also been assessed in connection with clinical depression, where there has been disagreement about the presence and direction of the 5-HT1A receptor binding.[8] In healthy subjects WAY-100,635 binding has been found to decline with age,[9] — though not all studies have found this relationship.[10][11]
What | Result | Subjects | Ref. |
---|---|---|---|
Age | Global decrease and particularly in parietal cortex and dorsolateral prefrontal cortex | 19 | [9] |
Age | No correlation found | 61 | [10] |
Age | No correlation detected | 25 | [11] |
Sex | Higher binding in females | 25 | [11] |
TCI self-transcendence and spiritual acceptance personality traits | Positive correlation in raphe region | 15 males | [7] |
Lifetime aggression | Negative correlation | 25 | [11] |
MADAM binding potential (serotonin transporter binding) | Positive correlation in the raphe nuclei and hippocampus | 12 males | [12] |
Genetic variation | Result | Subjects | Ref. |
HTR1A.(-1018)C>G polymorphism | No difference found | 35 | [13] |
SERT.5-HTTLPR polymorphism | Lower binding in "all brain regions" for SS or SL genotypes compared to LL | 35 | [13] |
Disease | Result | Subjects | Ref. |
Depressive (with primary, recurrent, familial mood disorders) | Reduction in raphe nucleus and mesiotemporal cortex | 12+8 | [14] |
Major depressive disorder (medicated and unmedicated) | Reduction in "many of the regions examined" | 25+18 | [15] |
Panic disorder in treated and untreated patients | Reducing in binding in raphe in both treated and untreated. Reduced binding in global postsynaptic regions for untreated, while no or little reduction for treated. | 9+7+19 | [16] |
Alzheimer disease | Decrease in right medial temporal cortex | 10+10 | [17] |
Radioligands
Labeled with the radioisotope carbon-11 it is used as a radioligand in positron emission tomography (PET) studies to determine neuroreceptor binding in the brain.[18] WAY-100,635 may be labeled in different ways with carbon-11: As [carbonyl-11C]WAY-100,635 or [O-methyl-11C]WAY-100,635, with [carbonyl-11C]WAY-100635 regarded as "far superior".[19] Labeled with tritium WAY-100,635 may also be used in autoradiography.[20] WAY-100,635 has higher 5-HT1A affinity than 8-OH-DPAT.[21]
Other actions
WAY-100,635 has also been found to increase the analgesic effects of opioid drugs in a dose-dependent manner, in contrast to 5-HT1A agonists such as 8-OH-DPAT which were found to reduce opioid analgesia.[22][23] However, since 5-HT1A agonists were also found to reduce opioid-induced respiratory depression and WAY-100,635 was found to block this effect,[24] it is likely that 5-HT1A antagonists might worsen this side effect of opioids. Paradoxically, chronic administration of the very high efficacy 5-HT1A agonist befiradol results in potent analgesia following an initial period of hyperalgesia, an effect most likely linked to desensitisation and/or downregulation of 5-HT1A receptors (i.e. analogous to a 5-HT1A antagonist-like effect).[25][26][27]
See also
- Binding potential
- Other radioligands for the serotonin system:
External links
- Lua error in package.lua at line 80: module 'strict' not found.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 7.0 7.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 9.0 9.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 10.0 10.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 11.0 11.1 11.2 11.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 13.0 13.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Dopamine agonists
- Piperazines
- Phenol ethers
- Amides
- Pyridines
- Serotonin antagonists